Scientists uncover bacterial mechanism for spreading antibiotic resistance

Researchers at the John Innes Centre have identified a three-gene system that causes bacteria to burst open, releasing virus-like particles that share DNA, including antibiotic resistance genes. The system, called LypABC, resembles a repurposed bacterial immune defense. The findings, published in Nature Microbiology, highlight how bacteria facilitate horizontal gene transfer.

Scientists at the John Innes Centre, in collaboration with the University of York and the Rowland Institute at Harvard, studied gene transfer agents (GTAs) in the bacterium Caulobacter crescentus. These particles, derived from ancient viruses, act as couriers, carrying DNA fragments between bacterial cells to spread useful traits like antibiotic resistance through horizontal gene transfer. A critical step is host cell lysis, where bacteria break open to release the GTAs, but the control mechanism was previously unknown. The team used deep sequencing to pinpoint the LypABC gene cluster, which encodes proteins essential for this lysis. Deleting lypABC prevented cell bursting and GTA release, while overexpressing it caused widespread lysis. A regulatory protein ensures tight control, as misregulation proves toxic to cells. Remarkably, LypABC components mimic a bacterial anti-phage immune system, suggesting bacteria have repurposed defense tools for gene sharing. Dr. Emma Banks, the study's first author and a Royal Commission for the Exhibition of 1851 Research Fellow, said: “What's particularly interesting is that LypABC looks like an immune system, yet bacteria are using it to release GTA particles. It suggests that immune systems can be repurposed to help bacteria share DNA with each other -- a process that can contribute to the spread of antibiotic resistance.” The research advances understanding of antimicrobial resistance spread. Future work will explore LypABC activation and its role in cell rupture.

Labaran da ke da alaƙa

Illustration of UC San Diego researchers' CRISPR pPro-MobV system spreading through bacterial biofilms to disable antibiotic resistance genes in a lab setting.
Hoton da AI ya samar

UC San Diego researchers describe a gene-drive-like CRISPR system designed to reduce antibiotic resistance in bacteria

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

Researchers at the University of California San Diego report they have developed a second-generation CRISPR-based “Pro-Active Genetics” system, called pPro-MobV, that is designed to spread between bacteria and disable antibiotic-resistance genes, including inside hard-to-treat biofilms.

Researchers at Caltech have discovered how viruses infect bacteria by disabling a key protein called MurJ, essential for cell wall construction. This mechanism, revealed through high-resolution imaging, suggests a new approach to combating antibiotic-resistant superbugs. The findings highlight convergent evolution in unrelated viruses blocking MurJ similarly.

An Ruwaito ta hanyar AI

Researchers from New England Biolabs and Yale University have developed the first fully synthetic system for engineering bacteriophages targeting Pseudomonas aeruginosa, a major antibiotic-resistant bacterium. Published in PNAS, the method uses digital DNA sequences to build viruses from scratch, bypassing traditional challenges in phage modification. This innovation aims to accelerate therapies against global antibiotic resistance threats.

Scientists have discovered a 5,000-year-old bacterium in a Romanian ice cave that resists several contemporary antibiotics. The microbe, isolated from permafrost, carries over 100 resistance genes and could inhibit dangerous superbugs. This finding highlights natural evolution of resistance and potential biotechnological applications.

An Ruwaito ta hanyar AI

Researchers have discovered genes that duplicated before the last universal common ancestor of all life, offering insights into evolution's earliest stages. These universal paralogs, present in nearly every organism, suggest protein production and membrane transport were among the first biological functions. The findings, published in Cell Genomics, highlight how ancient genetic patterns can reveal pre-LUCA history.

Researchers at Fred Hutch Cancer Center have created human-like monoclonal antibodies that prevent Epstein-Barr virus (EBV) from infecting immune cells. Using mice engineered with human antibody genes, the team identified antibodies targeting viral proteins gp350 and gp42, with one fully blocking infection in lab models. The findings, published in Cell Reports Medicine, could lead to therapies for transplant patients at risk of EBV-related complications.

An Ruwaito ta hanyar AI

Scientists at Johns Hopkins Medicine have pinpointed the gene KLF5 as a key driver of pancreatic cancer metastasis through epigenetic changes rather than DNA mutations. Using CRISPR technology, researchers found that KLF5 promotes tumor growth and invasion by altering DNA packaging and activating other cancer-related genes. The findings, published in Molecular Cancer, suggest potential new treatment targets.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi